An Open-Label Phase 2 Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Cell-Containing Agarose-Agarose Macrobeads in the Treatment of Patients With Treatment-Resistant, Metastatic Pancreatic or Colorectal Adenocarcinoma
Phase of Trial: Phase II
Latest Information Update: 02 Jun 2017
At a glance
- Drugs Encapsulated cell therapy (Primary)
- Indications Adenocarcinoma; Colorectal cancer; Pancreatic cancer
- Focus Therapeutic Use
- Acronyms Macrobead
- 02 Jun 2017 Results from NCT01053013 and NCT00283075 studies, presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
- 28 Sep 2016 Planned End Date changed from 1 Oct 2016 to 1 Dec 2018.
- 28 Sep 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Dec 2017.